Generic Name: umeclidinium (ue ME kli DIN ee um)
Brand Names: Incruse Ellipta
What is Incruse Ellipta?
Incruse Ellipta (umeclidinium) is an anticholinergic that works by relaxing muscles in the airways to improve breathing.
Incruse Ellipta is used to prevent airflow obstruction or bronchospasm in people with COPD (chronic obstructive pulmonary disease).
Incruse Ellipta may also be used for purposes not listed in this medication guide.
Incruse Ellipta is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack.
Before taking this medicine
You should not use Incruse Ellipta if you are allergic to umeclidinium or milk proteins.
To make sure this medicine is safe for you, tell your doctor if you have:
enlarged prostate; or
bladder obstruction or other urination problems.
FDA pregnancy category C. It is not known whether Incruse Ellipta will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.
It is not known whether umeclidinium passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
Incruse Ellipta is not approved for use by anyone younger than 18 years old.
How should I take Incruse Ellipta?
Take Incruse Ellipta exactly as it was prescribed for you. Follow all directions on your prescription label. Do not use this medicine in larger or smaller amounts or for longer than recommended.
Incruse Ellipta is a powder that comes with a special inhaler device preloaded with blister packs containing measured doses of the medicine. The device opens and loads a blister of Incruse Ellipta each time you use the inhaler. Follow the patient instructions provided with the inhaler device.
The usual dose is 1 inhalation per day. Use the medicine at the same time each day, and not more than once in a 24-hour period.
Incruse Ellipta is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack. Tell your doctor if any of your medicines seem to stop working as well in controlling your COPD.
You should not stop using this medicine suddenly. Stopping suddenly may make your condition worse.
Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.
Do not try to clean or take apart the inhaler device. Get your prescription refilled before you run out of medicine completely. Always use the new inhaler device provided with your refill.
Store at room temperature away from moisture, heat, and light. Keep the inhaler device in the sealed foil tray until ready to start using it.
Throw the inhaler device away 6 weeks after you have taken it out of the foil pouch, or if the dose indicator shows a zero, whichever comes first.
Incruse Ellipta dosing information
Usual Adult Dose for Chronic Obstructive Pulmonary Disease - Maintenance:
1 inhalation (62.5 mcg) orally once a day
Maximum dose: 1 inhalation every 24 hours
Use: Treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema
See also: Dosage Information (in more detail)
What happens if I miss a dose?
Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose. Do not use more than 1 inhalation in a single day.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking Incruse Ellipta?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
Incruse Ellipta side effects
Get emergency medical help if you have any of these signs of an allergic reaction to Incruse Ellipta: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
wheezing, choking, or other breathing problems after using this medication;
blurred vision, tunnel vision, eye pain, or seeing halos around lights;
painful or difficult urination; or
little or no urinating.
Common Incruse Ellipta side effects may include:
stuffy or runny nose, sinus pain, sneezing;
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
What other drugs will affect Incruse Ellipta?
Taking this medicine with other drugs that make you sleepy can worsen this effect. Ask your doctor before taking Incruse Ellipta with a sleeping pill, narcotic pain medicine, muscle relaxer, or medicine for anxiety, depression, or seizures.
Tell your doctor about all medicines you use, and those you start or stop using during your treatment with this medicine, especially:
cold or allergy medicine that contains an antihistamine (Benadryl and others);
medicine to treat Parkinson's disease;
medicine to treat excess stomach acid, stomach ulcer, motion sickness, or irritable bowel syndrome;
bladder or urinary medicines--darifenacin, fesoterodine, oxybutynin, tolterodine, solifenacin; or
bronchodilators--aclidinium, ipratropium, tiotropium.
This list is not complete. Other drugs may interact with umeclidinium, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.
More about Incruse Ellipta (umeclidinium)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 4 Reviews – Add your own review/rating
- Drug class: anticholinergic bronchodilators
Related treatment guides
Where can I get more information?
- Your pharmacist can provide more information about Incruse Ellipta.
- Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Incruse Ellipta only for the indication prescribed.
- Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2017 Cerner Multum, Inc. Version: 1.01.
Date modified: January 10, 2017
Last reviewed: November 05, 2014